SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs cvi42 Auto Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

cvi42 Auto Imaging

by Circle Cardiovascular Imaging Inc.

AI Verdict

These tools are adjacent rather than direct competitors, as they address different diagnostic modalities within cardiology. SensiCardiac Mobi is designed for real-time heart murmur diagnosis via acoustic analysis, leveraging an electronic stethoscope and mobile application. Conversely, cvi42 Auto Imaging focuses on comprehensive analysis of cardiovascular MR and CT images, aiding in detailed structural and functional assessment.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need an AI-powered mobile application for real-time, point-of-care assistance in diagnosing heart murmurs. This tool is ideal for physicians who require immediate analysis of acoustic heart signals from an electronic stethoscope to quickly differentiate between physiological and pathological sounds, aiding in initial screening and assessment.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if your primary need is comprehensive, AI-powered analysis of cardiovascular MR and CT images for detailed diagnosis and treatment planning. This software excels in automated contouring, segmentation, and quantitative analysis of cardiac function, flow, tissue characterization, and plaque, providing in-depth insights from visual data.

View cvi42 Auto Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	cvi42 Auto Imaging
Pricing	Contact for pricing	Starts at $5000 per license
Deployment	Hosted server environment (Linux OS) with a mobile application interface	On-premise (standalone workstation or client/server)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Tool A, SensiCardiac Mobi, is a mobile application with a user-friendly interface, scoring over 4 out of 5 in usability tests, suggesting ease of use for its specific function. Tool B, cvi42 Auto Imaging, also emphasizes a 'seamless user experience' and 'core simplicity' despite its comprehensive features and complex imaging analysis capabilities. Both tools appear designed for intuitive use within their respective domains.

Clinical Value

cvi42 Auto Imaging

Tool B, cvi42 Auto Imaging, offers a broader and deeper clinical impact by providing comprehensive, AI-powered quantitative analysis across multiple advanced imaging modalities (MR and CT), including detailed plaque quantification and functional assessments. While Tool A, SensiCardiac Mobi, provides valuable decision support for heart murmur diagnosis, Tool B's extensive capabilities address a wider range of complex cardiovascular conditions and treatment planning.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, stating 'contact for pricing' due to factors like licensing complexity and modularity. Without transparent pricing details, it is impossible to conduct a meaningful head-to-head comparison of their value propositions.

Enterprise Readiness

cvi42 Auto Imaging

Tool B, cvi42 Auto Imaging, demonstrates stronger enterprise readiness through its flexible deployment options (on-premise, networked, cloud compatibility), robust integration capabilities with DICOM and HL7, and widespread adoption in over 1,700 sites across 90+ countries, including many top hospitals. While Tool A explicitly states HIPAA compliance and BAA availability, Tool B's proven global scale and integration features indicate a more mature enterprise solution.

Innovation

cvi42 Auto Imaging

Tool B, cvi42 Auto Imaging, showcases greater innovation through its comprehensive, AI-powered quantitative analysis across multiple complex cardiovascular imaging modalities, including automated contouring, plaque quantification, and detailed functional assessments. While Tool A's mobile, point-of-care AI for acoustic analysis is innovative, Tool B pushes the boundaries of automated, in-depth diagnostic insights from advanced imaging data.

Support & Docs

cvi42 Auto Imaging

Tool B, cvi42 Auto Imaging, provides extensive support, including a 'world-class support and clinical team,' 'Real People, Real Time Support' in multiple languages and time zones, and high customer satisfaction scores. It also offers comprehensive online documentation (user manuals, system requirements) and various training options. Tool A, SensiCardiac Mobi, does not provide any specific information regarding its support or documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	cvi42 Auto Imaging
Primary Data Input/Analysis Focus	Acoustic heart signals from an electronic stethoscope to diagnose heart murmurs, differentiating physiological and pathological sounds.	Cardiovascular MR and CT images for comprehensive analysis, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.
Supported Medical Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Radiology, Vascular Surgery
Core AI-Powered Functionality	Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm to distinguish between normal/physiological and pathological heart murmurs; identifies S1, S2, and suspected murmurs.	AI-enabled automated contouring and segmentation; Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain); Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment); Vascular CT analysis; Quantitative analysis; 3D visualization and multiplanar reconstruction (MPR).
Required User-Provided Equipment/Data	Compatible electronic stethoscope (user-provided)	Cardiovascular MR and CT images
Company Name	DIACOUSTIC MEDICAL DEVICES (PTY)	Circle Cardiovascular Imaging

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and cvi42 Auto Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SensiCardiac Mobi and cvi42 Auto Imaging integrate into a physician's existing clinical workflow, and for what primary diagnostic purposes are they best suited?

SensiCardiac Mobi is a mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope in real-time during auscultation. In contrast, cvi42 Auto Imaging is an AI-powered software designed for comprehensive analysis of cardiovascular MR and CT images post-acquisition, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.

What level of integration can be expected with existing Electronic Health Record (EHR) systems for each tool, particularly regarding automated data population or report generation?

SensiCardiac Mobi, as a mobile application, captures and displays data, implying that direct EHR integration for automated data population or report generation would likely require specific development or manual input. cvi42 Auto Imaging is engineered for workflow optimization and seamless integration with existing systems and workflows, including direct integration into PACS and reporting systems like PowerScribe One, to reduce clerical workload and automate transcription.

What specific diagnostic capabilities do these tools offer to enhance accuracy in their respective clinical domains?

SensiCardiac Mobi analyzes acoustic heart signals to differentiate between physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs with reported accuracy above 95 percent for murmur detection. cvi42 Auto Imaging provides AI-enabled automated contouring and segmentation for cardiac MR and CT images, facilitating quantitative analysis of volumes, mass, function, signal intensity, and plaque for precise diagnosis and risk stratification.

What is the anticipated learning curve for physicians to become proficient with each tool, and how quickly can clinical benefits be realized?

SensiCardiac Mobi, as a mobile application for data capture and display, is likely designed for intuitive use, with usability scores averaging over 4 out of 5 in testing. cvi42 Auto Imaging, while offering comprehensive features, is described as easy to use and clinically validated, with its automated AI platform designed for efficient integration into clinical workflows to interpret studies faster.

What audit-trail features do these tools offer to track user actions, data modifications, or diagnostic decisions for compliance and quality assurance purposes?

The provided information for SensiCardiac Mobi does not explicitly detail audit-trail features. For cvi42 Auto Imaging, while not explicitly stated as 'audit-trail,' the system allows users to review, adjust, and approve AI-generated contours, ensuring results meet clinical standards, and analysis results are available on-screen and can be saved within the software for future review.

For a healthcare system with multiple sites, what are the key considerations for deploying and managing each tool across different locations?

SensiCardiac Mobi, being a mobile application, might offer flexibility in deployment across various sites for data capture, with its algorithm running on a hosted server environment. cvi42 Auto Imaging offers deployment as on-premise, stand-alone, or networked environment solutions, with an emphasis on on-premise deployment for data control, which would require careful planning for IT infrastructure and integration at each facility.